Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMC 3319947)

Published in World J Gastroenterol on April 07, 2012

Authors

Masahide Hamaguchi1, Noriyuki Takeda, Takao Kojima, Akihiro Ohbora, Takahiro Kato, Hiroshi Sarui, Michiaki Fukui, Chisato Nagata, Jun Takeda

Author Affiliations

1: Masahide Hamaguchi, Immunology Frontier Research Center at Osaka University, Osaka, Japan. mhamaguchi@frontier.kyoto-u.ac.jp

Articles citing this

What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol (2013) 1.49

What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol (2013) 0.99

Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis. Int J Endocrinol (2013) 0.98

Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. BMJ Open (2015) 0.86

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. Int J Mol Sci (2016) 0.86

Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh. World J Hepatol (2013) 0.85

Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers. PLoS One (2013) 0.82

Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease. World J Gastroenterol (2015) 0.80

Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL). Health Qual Life Outcomes (2016) 0.79

Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation. PLoS One (2016) 0.77

Association between UCP3 gene polymorphisms and nonalcoholic fatty liver disease in Chinese children. World J Gastroenterol (2013) 0.77

Association between serum γ-glutamyltranspeptidase and atherosclerosis: a population-based cross-sectional study. BMJ Open (2014) 0.75

Association of non-alcoholic fatty liver disease with renal stone disease detected on computed tomography. Eur J Radiol Open (2016) 0.75

Identification of cardiovascular risk components in urban Chinese with metabolic syndrome and application to coronary heart disease prediction: a longitudinal study. PLoS One (2013) 0.75

Assessment of Cardiovascular Parameters in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease. J Clin Res Pediatr Endocrinol (2015) 0.75

Comparison of first-year results of tenofovir and entecavir treatments of nucleos(t)ide-naive chronic hepatitis B patients with hepatosteatosis. Saudi J Gastroenterol (2015) 0.75

Articles cited by this

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA (2002) 25.68

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med (2006) 18.51

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology (2003) 9.36

Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology (2003) 8.75

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab (2004) 8.36

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med (2005) 6.23

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology (2005) 5.11

Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med (2000) 4.92

The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol (2007) 4.01

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis (2004) 3.06

Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr (2000) 2.79

Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol (2005) 2.67

How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol (2007) 2.48

Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology (2007) 2.22

Liver fat in the metabolic syndrome. J Clin Endocrinol Metab (2007) 2.17

Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol (2004) 1.98

Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci (2000) 1.85

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med (2005) 1.77

Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol (2005) 1.71

Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Am J Cardiol (2005) 1.55

Recent concepts in non-alcoholic fatty liver disease. Diabet Med (2005) 1.54

Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci (2005) 1.50

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut (2004) 1.44

Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis (2004) 1.35

Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol (2002) 1.34

The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis (2008) 1.23

Serum alanine aminotransferase activity in obese children. Acta Paediatr (1997) 1.17

Metabolic syndrome and NASH. Clin Liver Dis (2007) 1.08

Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res (2005) 1.07

Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. Diabetes Care (2003) 1.02

Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Med J (2007) 0.90

Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients. J Gastrointestin Liver Dis (2008) 0.90

Articles by these authors

Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet (2008) 9.39

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med (2005) 6.23

The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol (2007) 4.01

Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol (2004) 2.88

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol (2007) 2.71

The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. Prog Neuropsychopharmacol Biol Psychiatry (2007) 2.50

The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus. Hypertens Res (2011) 2.19

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol (2010) 2.06

Efficacy of intraoperative wound irrigation for preventing shunt infection. J Neurosurg Pediatr (2008) 2.02

Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res (2008) 2.02

Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer (2006) 1.93

Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab (2008) 1.91

Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol (2012) 1.68

Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion. Endocrinology (2009) 1.55

The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism (2008) 1.50

Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A (2006) 1.48

Eosinophil count is positively correlated with coronary artery calcification. Hypertens Res (2011) 1.47

Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat (2006) 1.46

A difference in systolic blood pressure between arms and between lower limbs is a novel risk marker for diabetic nephropathy in patients with type 2 diabetes. Hypertens Res (2013) 1.43

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci (2009) 1.43

Optimal home SBP targets for preventing the progression of diabetic nephropathy in patients with type 2 diabetes mellitus. J Hypertens (2015) 1.41

Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am J Epidemiol (2008) 1.41

Physiologic roles of 11beta-hydroxysteroid dehydrogenase type 2 in kidney. Metabolism (2006) 1.40

Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J Hum Genet (2009) 1.38

Depressive state and paresthesia dramatically improved by intravenous MgSO4 in Gitelman's syndrome. Intern Med (2004) 1.38

Sonographic evaluation of the peripheral nerve in diabetic patients: the relationship between nerve conduction studies, echo intensity, and cross-sectional area. J Ultrasound Med (2010) 1.36

Durable panicle blast-resistance gene Pb1 encodes an atypical CC-NBS-LRR protein and was generated by acquiring a promoter through local genome duplication. Plant J (2010) 1.35

Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms. J Biol Chem (2001) 1.34

Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes. FEBS Lett (2009) 1.31

Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA (2003) 1.29

Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun (2008) 1.29

Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis (2011) 1.27

Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr (2009) 1.27

Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem (2008) 1.24

REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology (2005) 1.20

Secretory granule-mediated co-secretion of L-glutamate and glucagon triggers glutamatergic signal transmission in islets of Langerhans. J Biol Chem (2002) 1.20

Tobacco smoking and lung cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol (2006) 1.19

Fruit and vegetable intake and mortality from cardiovascular disease are inversely associated in Japanese women but not in men. J Nutr (2008) 1.19

Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects. J Hum Genet (2007) 1.19

Endovascular treatment strategy for direct carotid-cavernous fistulas resulting from rupture of intracavernous carotid aneurysms. AJNR Am J Neuroradiol (2003) 1.18

Genomewide linkage and linkage disequilibrium analyses identify COL6A1, on chromosome 21, as the locus for ossification of the posterior longitudinal ligament of the spine. Am J Hum Genet (2003) 1.15

Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer (2002) 1.14

Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation. J Biol Chem (2001) 1.13

Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol (2007) 1.11

Expression of reg I alpha protein in human gastric cancers. Digestion (2004) 1.10

The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett (2006) 1.09

Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects. Diabetes (2006) 1.09

Invasion of epithelial cells and proteolysis of cellular focal adhesion components by distinct types of Porphyromonas gingivalis fimbriae. Infect Immun (2006) 1.09

Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol (2012) 1.08

Uterine balloon tamponade as a test to assess further treatment. Acta Obstet Gynecol Scand (2015) 1.08

Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol (2011) 1.07

Body mass index and mortality from all causes and major causes in Japanese: results of a pooled analysis of 7 large-scale cohort studies. J Epidemiol (2011) 1.07

Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.05

Genetic variation in the hypoxia-inducible factor-1alpha gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab (2005) 1.04

Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 1.04

Impact of alcohol intake on total mortality and mortality from major causes in Japan: a pooled analysis of six large-scale cohort studies. J Epidemiol Community Health (2010) 1.03

Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol (2006) 1.03

TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol (2003) 1.02

Diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan. Cancer Sci (2013) 1.01

Orphan nuclear receptor small heterodimer partner, a novel corepressor for a basic helix-loop-helix transcription factor BETA2/neuroD. Mol Endocrinol (2004) 1.01

Expression of inorganic phosphate/vesicular glutamate transporters (BNPI/VGLUT1 and DNPI/VGLUT2) in the cerebellum and precerebellar nuclei of the rat. Brain Res Mol Brain Res (2002) 1.00

Selective regulation of the chitin-induced defense response by the Arabidopsis receptor-like cytoplasmic kinase PBL27. Plant J (2014) 0.99

Diet based on the Japanese Food Guide Spinning Top and subsequent mortality among men and women in a general Japanese population. J Am Diet Assoc (2009) 0.99

Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes. Diabetes Care (2013) 0.98

Changes in endoscopic findings of gastritis after cure of H. pylori infection: multicenter prospective trial. Dig Endosc (2012) 0.98

Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep (2004) 0.98

Tobacco smoking and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol (2006) 0.98

Alcohol drinking and primary liver cancer: a pooled analysis of four Japanese cohort studies. Int J Cancer (2011) 0.97

Dietary glycemic index, glycemic load, and intake of carbohydrate and rice in relation to risk of mortality from stroke and its subtypes in Japanese men and women. Metabolism (2010) 0.97

Visual and auditory hallucinations during normal use of paroxetine for treatment of major depressive disorder. J Neuropsychiatry Clin Neurosci (2011) 0.96

Seaweed intake and blood pressure levels in healthy pre-school Japanese children. Nutr J (2011) 0.96

Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies. Int J Cancer (2011) 0.95

Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications. Diabetes Care (2003) 0.95

Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2010) 0.95

Alcohol drinking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol (2008) 0.94

A comparison of dietary habits among women in Japan and Hawaii. Public Health Nutr (2004) 0.94

Sonographic evaluation of the median nerve in diabetic patients: comparison with nerve conduction studies. J Ultrasound Med (2009) 0.94

Role of EGF Receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. J Mol Cell Cardiol (2002) 0.94

Localized malignant mesothelioma of the epithelial type occurring as a primary hepatic neoplasm: a case report with review of the literature. APMIS (2002) 0.94